Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.

Hae Jin Kim,In Kyung Jeong,Kyu Yeon Hur,Soo-Kyung Kim,Jung Hyun Noh,Sung Wan Chun,Eun Seok Kang,Eun-Jung Rhee,Sung Hee Choi

Diabetes & metabolism journal（2022）

引用 2|浏览6

暂无评分

摘要

ALO-PIO combination therapy during the early period exerts better glycemic control than ALO monotherapy and excellency in glycemic variability than low-dose sulfonylurea therapy in uncontrolled, drug-naïve or metformin failed T2DM patients.

查看译文

关键词

Alogliptin,Diabetes mellitus, type 2,Glimepiride,Glycemic control,Pioglitazone

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要